| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 74.27M | — |
| Operating expense | — | — |
| Net income | -17.58M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, PHAT returned -25.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -46.5% |
| 1 year | -25.5% |
| 5 years | -75.1% |
| All-time high | $44.05 (Feb 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in PHAT would be worth today ›No. Phathom Pharmaceuticals, Inc. has not paid a dividend in the past 12 months.
Phathom Pharmaceuticals, Inc. stock trades on NASDAQ under the ticker symbol PHAT.
Phathom Pharmaceuticals, Inc. is part of the Healthcare sector.
Phathom Pharmaceuticals, Inc. has a market cap of 717.59M USD, based on the latest quote.
Phathom Pharmaceuticals, Inc. is expected to report earnings around Oct 29, 2026. That date is an estimate and has not been confirmed by the company.
